At 4% gain per week, look for closer to a month! The shorts always put down the numbers when they are bad but once they take over the top spot from ARNA who had a hell of a head start, the shorts will have nothing to say except "thank you mam may I have another?"
I know, I control the world you live in, the air you breathe and the water you drink. I basically own you. How you got to dark side, I'll never know. Must be a glitch in my power switch. I called the drop down to eve for the day in another post. Guess you didn't see that one. I know how this story book ends. I've seen it before. This is just a re run with a different cast and will invest accordingly.
Why because they took it below $5 for a few hours yesterday? It didn't seem to cause that big of a stir. Look at the follow through volume today. It will end up very low compared to the last two days. If Retail wanted out, don't you think they would do it this week instead of waiting until a possible bear raid drops down to pick off a few stop limits? Why is it that WS has it in for the Retail investor short of you just saying it to be so? They had nothing to do with OREX's decision to pre announce the data. Your reasoning does not have any validity. I know the shorts are #$%$ that the $5 level held and they didn't get to say we caused a new 52 week low. I really don't think the script number will be affected in the least. The doctors aren't following wall street's every word on every drug provider that that they deal with. If the product works for their patient ands they tolerate it, they will re order. if not, they won#$%$ that simple.
Look for a pull back to even by EOD. The low volume and lack of negative articles is the real underlying win for today. Look for a small spike tomorrow morning if IMS numbers get leaked early. People will look for any small advantage to grab a quick $0.25 gain on this one this week.
It was an obvious attempt to manipulate the stock price downward in a quick fashion to allow shorts to cover their losses. When Orex released the early trial results, that one thing really #$%$ off a lot of shorts. This was their revenge for the shares they lost by covering all the way up to the $9.37 level. That's my story and I'm sticking to it. The drop permitted two things. It allowed the shorts to get out from higher buy in prices, allowed them to accumulate more shares lower and as they allow the PPS to slowly escalate back up, they will make money holding their newly acquired shares until they feel they are whole.
"Yet seven of eight analysts surveyed by Bloomberg recommend buying the stock, and more than half reiterated those calls this week. They project rising sales, call the bad news overblown, and say Orexigen’s drug Contrave is still the best. Their price targets range from 59 percent to 239 percent above Orexigen’s Wednesday closing price of $5.02."
“Some people sell stocks because they haven’t done the math or thought it through,” said Charles Duncan, an analyst at Piper Jaffray Cos. “It’s called a market inefficiency.” Duncan has an “overweight” rating on Orexigen shares and a price target of 59% to 239% above todays price."
Good, short to zero and then when you have to cover (which actually means buying the stock) there will be no one left to buy it. You will be broke fool. Just because you short something doesn't mean you own it. You need to buy it at some point to realize one gain and then quickly sell to unload shares. At zero, there will be nothing left for you. I hope you get your wish. Low volume today is a good sign. Shorts have moved on or have been instructed ENOUGH.
writing another regurgitation article about the whole early release data thing. Give it a rest dude. It's old news now. See how the volume is drying up on the stock. You did your job. You helped cut the PPS by $2 and screw thousands of people in doing so. No need to restate the same old thing over and over and over again. The shorts got what they paid you for now write another hit piece on MNKD or some other bio that you dislike.
Lets revisit in two weeks and see where they sit then? This will reverse because early data release is not worth a $2 haircut and no one has 100% data to prove or disprove how the trial would have turned out. People want to #$%$ about the early release because it caused some pain for shorts that got caught off guard. Once the narrative about the 50% being less, the shorts are now all about the data because it made up for their losses. The 100% data which we can all agree will never happen from this trial is now inconclusive regardless of what anyone says because it was terminated early.
It's not like they need to start the damn test tomorrow. It's not due until 2022. They will have 75 million coming soon in milestone payments to help offset it.
Just another lie spewing from a short. According to the all knowing eviljoe2013 the "secondary is already on the table" which implies that you have first hand information or have a link to a direct quote from the company itself that one is being pursued. Since I know you don't you fall in the dirty #$%$ bag category which is the only category I place shorts in these days.
I'm on Contrave you know the generic cocktail. Makes be want to lose weight and bash shorts at the same time. Awesome high too.
Nope, just here to bash the shorts and make their lives more miserable than the ones they've been dealt.
And you don't know that either. Just another shorty lie